Product
Investigational tetanus vaccine
1 clinical trial
1 indication
Indication
TetanusClinical trial
Randomized, Double-blind, Controlled Phase Ⅰ and Phase Ⅲ Clinical Trial to Evaluate the Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old PopulationStatus: Recruiting, Estimated PCD: 2024-09-01